Kelly Scarberry, MD

Kevin D. Cooper, MD, is a dermatologist at University Hospitals and Chair of the Department of Dermatology at UH Cleveland Medical Center. He is also the director of the Skin Diseases Research Center at Case Western Reserve University/University Hospitals, focusing on creating advances in skin diseases. As Chair of the department, Dr. Cooper and his team developed a clinical practice with 10 highly integrated dermatology suites throughout the region, all designed with an emphasis on excellence, respect and value. Dr. Cooper is also a co-inventor of the first biologic to be FDA-approved for psoriasis, and co-founded Fluence Therapeutics, a start-up biomedical company created to develop a novel photodynamic therapy for psoriasis and lymphoma.

Danny Barlev, MD, is a board-certified dermatologist at University Hospitals. He currently sees patients at UH Cleveland Medical Center and Two Chagrin Highlands location. Dr. Barlev has a particular interest in skin cancer prevention, general and pediatric dermatology, medical dermatology and community health. Dr. Barlev earned his medical degree and completed an internal medicine internship at the University of Missouri - Kansas City School of Medicine. He completed his residency training in dermatology at the University of Cincinnati Medical Center, where he was selected as resident of the month and served as chief resident. Dr. Barlev is a fellow of the American Academy of Dermatology.

Kord Honda, MD, joined University Hospitals Cleveland Medical Center as the Director of Dermatopathology in 2007 after completing his dermatopathology fellowship at the University of Cincinnati. Dr. Honda’s clinical interests include medical dermatology and cutaneous lymphomas. His research interests are in melanoma, quality care and decision making in dermatology. Dr. Honda collaborates extensively with researchers in other disciplines and enjoys mentoring residents, fellows, medical students and faculty members.